CTRI/2024/05/068043尚未招募4 期
A prospective open-label, multi-centre study to evaluate the effectiveness of personalized coaching program when compared to the standard of care in the management of type 2 diabetes - NI
Ragus Healthcare Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1 Patients with age group of above 18 years both men and women
- •2 Patients with history of diabetes with HbA1c greater than 7 with T2DM condition
- •3 Patients willing to sign an informed consent document
- •4 Patients who have not participated in any clinical study in the past 30 days
排除标准
- •1.Patients diagnosed with type 1 diabetes mellitus or diabetic ketoacidosis
- •2.Pregnant and lactating subjects
- •3.Patients with severe co-morbidities or disease conditions (Cardiac or Renal or Cancer)
- •4.End-stage renal disease or severe renal impairment (creatinine clearance more 30 ml per min)
研究者
相似试验
招募中
3 期
A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)JPRN-jRCT2011230024Myoishi Masafumi100
已完成
3 期
Evaluation of DEAT0217 versus standard of care to compare effectiveness and safety in treating moderate psoriasis in adult patientsAdult patients diagnosed with mild to moderate psoriasis.Skin and Connective Tissue DiseasesISRCTN28479470Devintec SAG42
已完成
不适用
This is an open label multi centre study to evaluate the safety and efficacy of anti acne formulation in patients with facial acne.CTRI/2015/12/006463A Menarini India Private Limited36
招募中
不适用
Clinical Evaluation of Low Cost Single use Safety syringeCTRI/2017/06/008864Indian Council of Medical Research ICMR
进行中（未招募）
不适用
An non-blinded, mulicenter study to investigate the mechanisms which are involved in the interaction of red blood cells with the study drug IgPro10 in patients with chronic immune thrombocytopenic purpura (ITP) who have shown signs of hemolysis (a breakdown or destruction of red blood cells).Chronic immune thrombocytopenic purpura (ITP)MedDRA version: 16.0Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-000263-27-BGCSL Behring GmbH150